| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
STOCKHOLM—Although researchers have been able to catalogue many of the proteins that comprise the various proteomes, much of this characterization has been performed outside of the context of the cell where the proteins function. Advances in microscopy, however, have opened the possibility of high-throughput proteomic analysis within the subcellular milieu. Recently, researchers at the Royal Institute of Technology and Uppsala University performed a pilot study to develop a subcellular atlas of the human proteome.
 
As they report in Molecular and Cellular Proteomics, the researchers combined fluorescently tagged antibodies with tissue and cell arrays to characterize the subcellular localization of hundreds of proteins in three cancer cell lines. First, they used bioinformatics to identify protein epitopes that they then used to generate monospecific polyclonal antibodies. They then probed tissue and cell arrays with each antibody in combination with three probes identifying the nucleus, tubulin, and the endoplasmic reticulum, and had pathologists annotate the resulting confocal microscopy images manually.
 
The researchers compared their results with the Gene Ontology (GO) annotations for the same proteins to develop a score map. In more than 80% of the cases, the cellular annotation and GO results matched. When they looked at all three cell lines, however, the agreement with GO dropped to 60%, suggesting that events might be occurring within the cell lines that cannot be predicted strictly from GO terminology.
 
The researchers have added the images and annotation data to the open-access Human Protein Atlas where it can be analyzed in the context of other annotated information. Their goal is to include similar data for all the proteins in the atlas.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue